American Old Master: The Art and Science of Thomas Eakins [Science in the Arts]
Written by Dominiczak, M. H. on January 28, 2012 – 8:01 pm -Posted in Clinical Chemistry, Other Areas of Clinical Chemistry | Comments Off
Midregional Proadrenomedullin for Prediction of Cardiovascular Events in Coronary Artery Disease: Results from the AtheroGene Study [Proteomics and Protein Markers]
December 28, 2011 – 10:37 pmBACKGROUND: Midregional proadrenomedullin (MR-proADM) is a newly identified prognostic marker in ...
Comments OffInfluence of Population Selection on the 99th Percentile Reference Value for Cardiac Troponin Assays [Proteomics and Protein Markers]
December 28, 2011 – 10:37 pmOBJECTIVE: We sought to determine the effect of patient selection on ...
Comments OffAbsolute and Relative Kinetic Changes of High-Sensitivity Cardiac Troponin T in Acute Coronary Syndrome and in Patients with Increased Troponin in the Absence of Acute Coronary Syndrome [Proteomics and Protein Markers]
December 28, 2011 – 10:37 pmBACKGROUND: We evaluated kinetic changes of high-sensitivity cardiac troponin T (hs-cTnT) ...
Comments OffCirculating Troponin As Measured by a Sensitive Assay for Cardiovascular Risk Assessment in Primary Prevention [Lipids, Lipoproteins, and Cardiovascular Risk Factors]
December 28, 2011 – 10:37 pmBACKGROUND: Measuring circulating cardiac troponin using novel sensitive assays has revealed ...
Comments OffCystatin C and Estimated Glomerular Filtration Rate as Predictors for Adverse Outcome in Patients with ST-Elevation and Non-ST-Elevation Acute Coronary Syndromes: Results from the Platelet Inhibition and Patient Outcomes Study [Lipids, Lipoproteins, and Cardiovascular Risk Factors]
December 28, 2011 – 10:37 pmBACKGROUND: We evaluated the predictive ability of cystatin C and creatinine-based ...
Comments OffRosuvastatin, Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Cholesterol Response: the JUPITER Trial [Lipids, Lipoproteins, and Cardiovascular Risk Factors]
December 28, 2011 – 10:37 pmBACKGROUND: Although statin therapy is known to increase concentrations of PCSK9, ...
Comments OffAssociation of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study [Lipids, Lipoproteins, and Cardiovascular Risk Factors]
December 28, 2011 – 10:37 pmBACKGROUND: Growth differentiation factor 15 (GDF-15) is produced by cardiomyocytes and ...
Comments OffCounterpoint: Standardization of Cardiac Troponin I Assays Will Not Occur in My Lifetime [Point/Counterpoint]
December 28, 2011 – 10:37 pmComments Off
Point: Put Simply, Standardization of Cardiac Troponin I Is Complicated [Point/Counterpoint]
December 28, 2011 – 10:37 pmComments Off
Counterpoint: Detection of Myocardial Infarction–Is It All Troponin? Role of New Markers [Point/Counterpoint]
December 28, 2011 – 10:37 pmComments Off
Point: Detection of Myocardial Infarction–Is It All Troponin? [Point/Counterpoint]
December 28, 2011 – 10:37 pmComments Off
Clopidogrel and CYP2C19 Testing: Ready for Clinical Prime Time? [Opinions]
December 28, 2011 – 10:37 pmComments Off
Are There Really Biomarkers of Vulnerable Plaque? [Opinions]
December 28, 2011 – 10:37 pmComments Off
Troponin Release–Reversible or Irreversible Injury? Should We Care? [Opinions]
December 28, 2011 – 10:37 pmComments Off
Metabolomics and Cardiovascular Biomarker Discovery [Reviews]
December 28, 2011 – 10:37 pmBACKGROUND: Metabolomics, the systematic analysis of low molecular weight biochemical compounds ...
Comments Off